The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Head And Neck Squamous Cell Carcinoma Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%.
The global Head And Neck Squamous Cell Carcinoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Head And Neck Squamous Cell Carcinoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Head And Neck Squamous Cell Carcinoma Treatment market. Surgical Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head And Neck Squamous Cell Carcinoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head And Neck Squamous Cell Carcinoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head And Neck Squamous Cell Carcinoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head And Neck Squamous Cell Carcinoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head And Neck Squamous Cell Carcinoma Treatment covered in this report include Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche and Celgene, etc.
The global Head And Neck Squamous Cell Carcinoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
AbbVie
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
GlaxoSmithKline
Teva
Roche
Celgene
Global Head And Neck Squamous Cell Carcinoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head And Neck Squamous Cell Carcinoma Treatment market, Segment by Type:
Surgical Therapy
Radiation Therapy
Drug Treatment
Global Head And Neck Squamous Cell Carcinoma Treatment market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Head And Neck Squamous Cell Carcinoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%.
The global Head And Neck Squamous Cell Carcinoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Head And Neck Squamous Cell Carcinoma Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Head And Neck Squamous Cell Carcinoma Treatment market. Surgical Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Head And Neck Squamous Cell Carcinoma Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Head And Neck Squamous Cell Carcinoma Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Head And Neck Squamous Cell Carcinoma Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Head And Neck Squamous Cell Carcinoma Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Head And Neck Squamous Cell Carcinoma Treatment covered in this report include Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche and Celgene, etc.
The global Head And Neck Squamous Cell Carcinoma Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
AbbVie
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
GlaxoSmithKline
Teva
Roche
Celgene
Global Head And Neck Squamous Cell Carcinoma Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Head And Neck Squamous Cell Carcinoma Treatment market, Segment by Type:
Surgical Therapy
Radiation Therapy
Drug Treatment
Global Head And Neck Squamous Cell Carcinoma Treatment market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Head And Neck Squamous Cell Carcinoma Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Head And Neck Squamous Cell Carcinoma Treatment
1.1 Head And Neck Squamous Cell Carcinoma Treatment Market Overview
1.1.1 Head And Neck Squamous Cell Carcinoma Treatment Product Scope
1.1.2 Head And Neck Squamous Cell Carcinoma Treatment Market Status and Outlook
1.2 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2018-2029)
1.4 Global Head And Neck Squamous Cell Carcinoma Treatment Historic Market Size by Region (2018-2023)
1.5 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
1.6.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
1.6.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
1.6.4 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size (2018-2029)
2 Head And Neck Squamous Cell Carcinoma Treatment Market by Type
2.1 Introduction
2.1.1 Surgical Therapy
2.1.2 Radiation Therapy
2.1.3 Drug Treatment
2.2 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Head And Neck Squamous Cell Carcinoma Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Type (2018-2029)
3 Head And Neck Squamous Cell Carcinoma Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Head And Neck Squamous Cell Carcinoma Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Head And Neck Squamous Cell Carcinoma Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Head And Neck Squamous Cell Carcinoma Treatment Revenue Breakdown by Application (2018-2029)
4 Head And Neck Squamous Cell Carcinoma Treatment Competition Analysis by Players
4.1 Global Head And Neck Squamous Cell Carcinoma Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Head And Neck Squamous Cell Carcinoma Treatment as of 2022)
4.3 Date of Key Players Enter into Head And Neck Squamous Cell Carcinoma Treatment Market
4.4 Global Top Players Head And Neck Squamous Cell Carcinoma Treatment Headquarters and Area Served
4.5 Key Players Head And Neck Squamous Cell Carcinoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Head And Neck Squamous Cell Carcinoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.1.4 Amgen Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 AbbVie
5.2.1 AbbVie Profile
5.2.2 AbbVie Main Business
5.2.3 AbbVie Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.2.4 AbbVie Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 AbbVie Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.4.4 AstraZeneca Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.5.4 Eli Lilly Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 GlaxoSmithKline
5.6.1 GlaxoSmithKline Profile
5.6.2 GlaxoSmithKline Main Business
5.6.3 GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.6.4 GlaxoSmithKline Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 GlaxoSmithKline Recent Developments
5.7 Teva
5.7.1 Teva Profile
5.7.2 Teva Main Business
5.7.3 Teva Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.7.4 Teva Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Teva Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.8.4 Roche Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Recent Developments
5.9 Celgene
5.9.1 Celgene Profile
5.9.2 Celgene Main Business
5.9.3 Celgene Head And Neck Squamous Cell Carcinoma Treatment Products, Services and Solutions
5.9.4 Celgene Head And Neck Squamous Cell Carcinoma Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Celgene Recent Developments
6 North America
6.1 North America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Head And Neck Squamous Cell Carcinoma Treatment Market Dynamics
11.1 Head And Neck Squamous Cell Carcinoma Treatment Industry Trends
11.2 Head And Neck Squamous Cell Carcinoma Treatment Market Drivers
11.3 Head And Neck Squamous Cell Carcinoma Treatment Market Challenges
11.4 Head And Neck Squamous Cell Carcinoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
